The Antibody Contract Manufacturing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The historical growth trend in the Antibody Contract Manufacturing Global Market Report 2024 market shows rapid development in recent years. The market size is predicted to increase from $14.8 billion in 2024 to $16.84 billion in 2025, with a compound annual growth rate (CAGR) of 13.8%.
The Antibody Contract Manufacturing Global Market is expected to reach a market size of $29.86 billion in 2029, growing at a compound annual growth rate (CAGR) of 15.4%.
Download Your Free Sample of the 2025 Antibody Contract Manufacturing Market Report and Uncover Key Trends Now!The key drivers in the antibody contract manufacturing market are:
• Increased R&D spending in the healthcare sector
• Expansion of bispecific and multispecific antibodies
• The rise in utilization of antibody-drug conjugates (ADCs)
• Growth in government initiatives supporting healthcare infrastructure.
The antibody contract manufacturing market covered in this report is segmented –
1) By Product: Monoclonal Antibodies, Polyclonal Antibodies, Other Products
2) By Source: Mammalian, Microbial
3) Scale Of Operation: Preclinical, Clinical, Commercial
4) By End-User: Biopharmaceutical Companies, Research Laboratories, Other End Users
The key trends in the antibody contract manufacturing market are:
• Digitalization and data analytics are becoming pivotal in the antibody contract manufacturing market.
• Advanced upstream technologies are highly influencing market trends.
• Novel downstream processing techniques are an emerging trend in the market.
• The integration of contract development and manufacturing (CDMO) is shaping the future of the industry.
The major players in the antibody contract manufacturing market are:
• AbbVie Inc
North America was the largest region in the antibody contract manufacturing market in 2024